Herrera, A. F., Lavie, D., Johnson, N. A., Avigdor, A., Borchmann, P., Andreadis, C., Bazargan, A., Gregory, G., Keane, C., Inna, T., Vucinic, V., Zinzani, P. L., Zhang, H., Pillai, P., Marinello, P., & Timmerman, J. (n.d.). p1087: FAVEZELIMAB (ANTI–LAG-3) AND PEMBROLIZUMAB CO-BLOCKADE IN PATIENTS WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA WHO PROGRESSED AFTER ANTI–PD-1 THERAPY: AN OPEN-LABEL PHASE 1/2 STUDY. HemaSphere, 6, 977–978. http://access.bl.uk/ark:/81055/vdc_100158013878.0x000003